Kirin's Yoshimura on Health Science Business Strategy

Toru Yoshimura, Senior Executive Officer at Kirin, discusses the company’s business strategy and expansion plans for its health science business. He speaks with Shery Ahn and Avril Hong on Bloomberg: The Asia Trade. (Source: Bloomberg)

Read Full Article

Kirin’s Yoshimura on Health Science Business Strategy

Related Posts

Oil prices dip as investors assess trajectory of US-Iran tensions

Blue Owl permanently halts redemptions at fund aimed at retail investors

Purpose Investments Announces Completion and Exchange Ratio for Merger, Special Capital Gain Distribution, and Related Matters

Welcome to the era of anarchic antitrust

Wine giant Gallo closing Napa Valley facility, laying off dozens of workers

Popular Stories

Iran Dangerously Misunderstands Its Situation

U2 Attacks MAGA as ‘People of the Lie’ in Renee Good Protest Song ‘American Obituary’

‘I do not trust them’ – top streamers left concerned by Discord age checks

Scottish Greens’ call to evict US military from Prestwick Airport slapped down

Tokyos strategic US investment surge puts China on edge

Welcome Back!

Create New Account!

Retrieve your password